I am herewith sending you a message as the President of the Japanese Society of Clinical Neuropsychopharmacology (JSCNP). At the Executive Board in November, 2016, I was elected as the eighth President of the Society, succeeding the former President Professor Otani. In the 2017-2018 term, I will do my best for the progress of the Society, in collaboration with other members, especially the Vice-president Professor Someya and Executive Board directors of JSCNP.
From historical aspects, the JSCNP was founded in 1991 with the concise and clear objective "To develop clinical neuropsychopharmacology and improve pharmacotherapy in psychiatry". The major topics covered by the Society are pharmacokinetics, pharmacodynamics, pharmacogenetics, treatment algorithms of psychiatric disorders, individualization and optimization of drug treatment, drug interactions. The major activities of the Society include annual meeting, training and certification of the experts on clinical neuropsychopharmacology, awarding of the Paul Janssen Prize to the best articles in each year, scholarship to study abroad, publishing of the Textbook of Clinical Neuropsychopharmacology (now the third edition) and the official journal Clinical Neuropsychopharmacology and Therapeutics (CNPT).
With vigorous activities by members strongly sympathized to the objective of the Society, the JSCNP has progressed steadily, and the number of members has now exceeded 1200. The JSCNP has produced many distinguished researchers such as professors of psychiatry.
In line with the foundation objective and past activities, the first priority of the JSCNP should be specific and distinctive activities of its own. Considering the necessity of translational research and the transition of psychiatric diagnosis, we may also need to absorb updated knowledge from and keep close cooperation with other academic societies in the future.
I sincerely ask the members of the JSCNP to give encouraging assistance to the Society for further progress, and welcome new members who are interested in the field to the Society.
Tsuyoshi Kondo, M.D., Ph.D.
Professor, Department of Neuropsychiatry Graduate School of Medicine University of the Ryukyus